Taken together, the combination of productive neoantigen T cell recognition and epigenetically directed intra-tumor infiltration of CD8+ T lymphocytes characterizes a sizable group of IDH wild-type GBM patients who experience a more favorable prognosis. Here, CD8A is linked to neoplasm.